on behalf of the EPIC investigators. Randomised trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: results at six months - Topol, E J; Califf, R M; Weisman, H F; Elli, S G; Tcheng, J E; Worley, S; Ivanhoe, R; George, B S; Fintel, D; Weston, M; Sigmon, K; Anderson, K M; Lee, K L; Willerson, J T (Lancet, 1994)